H E Shannon - JoVE Visualize

Showing results (71-80 of 95) with videos related to

Pageof 10

Sort By:

Schizophrenia Research|April 29, 2000

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and miceH E Shannon, K Rasmussen, F P Bymaster, et al.

The Journal of Urology|August 1, 1996

Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractilityB P Kropp, B D Sawyer, H E Shannon, et al.

Life Sciences|January 1, 1995

Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.

Dementia (Basel, Switzerland)|July 1, 1996

PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and manL Farde, T Suhara, C Halldin, et al.

Journal of Veterinary Pharmacology and Therapeutics|November 13, 2008

Nonlinear mixed effects pharmacokinetic/pharmacodynamic analysis of the anticonvulsant ameltolide (LY201116) in a canine seizure modelP R Territo, H E Shannon, K Newhall, et al.

Journal of Medicinal Chemistry|January 23, 1998

Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.

Neuroreport|December 17, 1998

Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.

Journal of Medicinal Chemistry|February 17, 1998

1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999

Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.

Schizophrenia Research|May 10, 2001

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidanceT Rasmussen, A Fink-Jensen, P Sauerberg, et al.

Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:

Pageof 10

Schizophrenia Research|April 29, 2000

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and miceH E Shannon, K Rasmussen, F P Bymaster, et al.

The Journal of Urology|August 1, 1996

Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractilityB P Kropp, B D Sawyer, H E Shannon, et al.

Life Sciences|January 1, 1995

Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.

Dementia (Basel, Switzerland)|July 1, 1996

PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and manL Farde, T Suhara, C Halldin, et al.

Journal of Veterinary Pharmacology and Therapeutics|November 13, 2008

Nonlinear mixed effects pharmacokinetic/pharmacodynamic analysis of the anticonvulsant ameltolide (LY201116) in a canine seizure modelP R Territo, H E Shannon, K Newhall, et al.

Journal of Medicinal Chemistry|January 23, 1998

Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.

Neuroreport|December 17, 1998

Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.

Journal of Medicinal Chemistry|February 17, 1998

1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999

Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.

Schizophrenia Research|May 10, 2001

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidanceT Rasmussen, A Fink-Jensen, P Sauerberg, et al.

Pageof 10